Bionano Genomics, Inc(NASDAQ:BNGO) 
Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the sear...
Website: http://www.bionanogenomics.com
Founded: 2003
Full Time Employees: 97
CEO: Erik Holmlin
Sector: Healthcare
Industry: Diagnostics & Research
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 3.24
H 3.24
L 2.99
C 3.03
V 90,961
10EMA 3.03
20EMA 3.03
60EMA 3.03
120EMA 3.03
250EMA 3.03